Large scale preparation of human MHC class II+ integrin β1+ Tregs

Journal of Immunological Methods

Volumn 360, Issue 1-2, 2010, Pages 96-102

  Bonnin, Brigitte ^a   Correll, Anita ^b   Swiatek de Lange, Magdalena ^c   Lenter, Martin ^c   Schneider, Franz Joseph ^c   Wijdenes, John ^a   Jonuleit, Helmut ^b   Becker, Christian ^b  

^a Gen Probe   (France)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

MHC class II expression; Regulatory T cells; Subpopulation; Treg isolation procedure

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA4BETA7 INTEGRIN; BETA1 INTEGRIN; INTERLEUKIN 7 RECEPTOR; LYMPHOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 4; CD4 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; HLA ANTIGEN CLASS 2; INTERLEUKIN 2 RECEPTOR ALPHA;

ALLERGY; ANTIGEN EXPRESSION; ARTICLE; CELL ISOLATION; CELL SUBPOPULATION; CONTROLLED STUDY; FEVER; HUMAN; HUMAN CELL; LEUKAPHERESIS; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REPRODUCIBILITY; BIOSYNTHESIS; CELL CULTURE; FLOW CYTOMETRY; HIGH THROUGHPUT SCREENING; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOMAGNETIC SEPARATION; METABOLISM; PATHOLOGY; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD4; CELLS, CULTURED; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HIGH-THROUGHPUT SCREENING ASSAYS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNE TOLERANCE; IMMUNOMAGNETIC SEPARATION; INTEGRIN ALPHA4BETA1; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKAPHERESIS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 77955660306     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2010.06.014     Document Type: Article

References (17)

1. Baecher-Allan C., Wolf E., Hafler D.A. MHC class II expression identifies functionally distinct human regulatory T cells. J. Immunol. 2006, 176:4622.
2. Battaglia A., Buzzonetti A., Monego G., Peri L., Ferrandina G., Fanfani F., Scambia G., Fattorossi A. Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer. Immunology 2008, 123:129.
3. Becker C., Hoschutzky H., Rist W., Lenter M., Schneider F.J., Jonuleit H. Generation of monoclonal antibodies against human regulatory T cells. J. Immunol. Meth. 2010, 353:62.
4. Borsellino G., Kleinewietfeld M., Di M.D., Sternjak A., Diamantini A., Giometto R., Hopner S., Centonze D., Bernardi G., Dell'acqua M.L., Rossini P.M., Battistini L., Rotzschke O., Falk K. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007, 110:1225.
5. Correll A., Tuettenberg A., Becker C., Jonuleit H. Increased regulatory T-cell frequencies in patients with advanced melanoma correlate with a generally impaired T-cell responsiveness and are restored after dendritic cell-based vaccination. Exp Dermatol. 2010 May 25, 19:e213.
6. Curiel T.J., Coukos G., Zou L., Alvarez X., Cheng P., Mottram P., Evdemon-Hogan M., Conejo-Garcia J.R., Zhang L., Burow M., Zhu Y., Wei S., Kryczek I., Daniel B., Gordon A., Myers L., Lackner A., Disis M.L., Knutson K.L., Chen L., Zou W. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 2004, 10:942.
7. D'Alessio F.R., Tsushima K., Aggarwal N.R., West E.E., Willett M.H., Britos M.F., Pipeling M.R., Brower R.G., Tuder R.M., McDyer J.F., King L.S. CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J. Clin. Invest. 2009, 119:2898.
8. Ermann J., Hoffmann P., Edinger M., Dutt S., Blankenberg S.G., Higgins J.P., Negrin R.S., Fathman C.G., Strober S. Only the CD62L+subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD. Blood 2005, 105:2220.
9. Fritzsching B., Oberle N., Pauly E., Geffers R., Buer J., Poschl J., Krammer P., Linderkamp O., Suri-Payer E. Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death. Blood 2006, 108:3371.
10. Hoffmann P., Boeld T.J., Eder R., Albrecht J., Doser K., Piseshka B., Dada A., Niemand C., Assenmacher M., Orsó E., Andreesen R., Holler E., Edinger M. Isolation of CD4+CD25+ regulatory T cells for clinical trials. Biol. Blood Marrow Transplant. 2006, 12:267.
11. Jonuleit H., Schmitt E. Regulatory T-cells in antitumor therapy: isolation and functional testing of CD4+CD25+ regulatory T-cells. Meth. Mol. Med. 2005, 109:285.
12. Miyara M., Yoshioka Y., Kitoh A., Shima T., Wing K., Niwa A., Parizot C., Taflin C., Heike T., Valeyre D., Mathian A., Nakahata T., Yamaguchi T., Nomura T., Ono M., Amoura Z., Gorochov G., Sakaguchi S. Functional delineation and differentiation dynamics of human CD4(+) T cells expressing the FoxP3 transcription factor. Immunity 2009, 30:899.
13. Nagata S., Ise T., Pastan I. Fc receptor-like 3 protein expressed on IL-2 nonresponsive subset of human regulatory T cells. J. Immunol. 2009, 182:7518.
14. Powell D.J., Parker L.L., Rosenberg S.A. Large-scale depletion of CD25+ regulatory T cells from patient leukapheresis samples. J. Immunother. 2005, 28:403.
15. Stassen M., Fondel S., Bopp T., Richter C., Muller C., Kubach J., Becker C., Knop J., Enk A.H., Schmitt S., Schmitt E., Jonuleit H. Human CD25+ regulatory T cells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells. Eur. J. Immunol. 2004, 34:1303.
16. Tang Q., Bluestone J.A. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 2008, 9:239.
17. Valmori D., Merlo A., Souleimanian N.E., Hesdorffer C.S., Ayyoub M. A peripheral circulating compartment of natural naive CD4 Tregs. J. Clin. Invest. 2005, 115:1953.